Agency Information Collection Activities: Submission for OMB Review; Comment Request, 32657-32658 [2013-12934]
Download as PDF
Federal Register / Vol. 78, No. 105 / Friday, May 31, 2013 / Notices
this system should follow the same
instructions indicated under
‘‘Notification Procedure.’’ The request
should reasonably identify the record,
specify the information contested, state
the corrective action sought, and
provide the reasons for the correction,
with supporting justification.
RECORD SOURCE CATEGORIES:
All information will be collected
directly from the individual applicants/
users of the Web site, when they
complete the online application forms.
EXEMPTIONS CLAIMED FOR THIS SYSTEM:
None.
Dated: May 21, 2013.
Carolyn M. Clancy,
AHRQ Director.
[FR Doc. 2013–12671 Filed 5–30–13; 8:45 am]
BILLING CODE 4160–90–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention (CDC)
tkelley on DSK3SPTVN1PROD with NOTICES
Board of Scientific Counselors,
National Center for Environmental
Health/Agency for Toxic Substances
and Disease Registry (BSC, NCEH/
ATSDR)
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC),
announces the following meeting of the
aforementioned committee:
Times and Dates: 8:30 a.m.–3:00 p.m.,
June 27, 2013; 8:30 a.m.–12:00 p.m.,
June 28, 2013.
Place: CDC, 4770 Buford Highway,
Atlanta, Georgia 30341.
Status: Open to the public, limited
only by the space available. The meeting
room accommodates approximately 60
people.
Purpose: The Secretary, Department
of Health and Human Services (HHS)
and by delegation, the Director, CDC
and Administrator, NCEH/ATSDR, are
authorized under Section 301(42 U.S.C.
241) and Section 311(42 U.S.C. 243) of
the Public Health Service Act, as
amended, to: (1) Conduct, encourage,
cooperate with, and assist other
appropriate public authorities, scientific
institutions, and scientists in the
conduct of research, investigations,
experiments, demonstrations, and
studies relating to the causes, diagnosis,
treatment, control, and prevention of
physical and mental diseases and other
impairments; (2) assist states and their
political subdivisions in the prevention
VerDate Mar<15>2010
17:40 May 30, 2013
Jkt 229001
of infectious diseases and other
preventable conditions and in the
promotion of health and well being; and
(3) train state and local personnel in
health work. The BSC, NCEH/ATSDR
provides advice and guidance to the
Secretary, HHS; the Director, CDC and
Administrator, ATSDR; and the
Director, NCEH/ATSDR, regarding
program goals, objectives, strategies, and
priorities in fulfillment of the agency’s
mission to protect and promote people’s
health. The board provides advice and
guidance that will assist NCEH/ATSDR
in ensuring scientific quality,
timeliness, utility, and dissemination of
results. The board also provides
guidance to help NCEH/ATSDR work
more efficiently and effectively with its
various constituents and to fulfill its
mission in protecting America’s health.
Matters To Be Discussed: The agenda
items for the BSC Meeting on June 27–
28, 2013 will include NCEH/ATSDR
Office of the Director updates:
Environmental Health Emergencies
updates, Lead Poisoning Prevention
Activities updates, Epi Aids at NCEH/
ATSDR update, Strategic Planning
updates; and updates by BSC Federal
Expert members on current activities at
the National Institute for Occupational
Safety and Health, U.S. Department of
Energy, National Institute for
Environmental Health Services and the
U.S. Environmental Protection Agency.
Agenda items are subject to change as
priorities dictate.
SUPPLEMENTARY INFORMATION: The
public comment period is scheduled on
Thursday, June 27, 2013 from 2:30 p.m.
until 2:45 p.m., and on Friday, June 28,
2013 from 10:00 a.m. until 10:15 a.m.
Contact Person for More Information:
Sandra Malcom, Committee
Management Specialist, NCEH/ATSDR,
CDC, 4770 Buford Highway, Mail Stop
F–61, Chamblee, Georgia 30345;
telephone 770/488–0575 or 770/488–
0755, Fax: 770/488–3377; Email:
smalcom@cdc.gov. The deadline for
notification of attendance is June 21,
2013.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities for both the
Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention (CDC).
[FR Doc. 2013–12912 Filed 5–30–13; 8:45 am]
BILLING CODE 4163–18–P
PO 00000
Frm 00036
Fmt 4703
Sfmt 4703
32657
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Medicare & Medicaid
Services
[Document Identifiers: CMS–10302, CMS–
R–290 and CMS–10437]
Agency Information Collection
Activities: Submission for OMB
Review; Comment Request
Centers for Medicare &
Medicaid Services, HHS.
In compliance with the requirement
of section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995, the
Centers for Medicare & Medicaid
Services (CMS), Department of Health
and Human Services, is publishing the
following summary of proposed
collections for public comment.
Interested persons are invited to send
comments regarding this burden
estimate or any other aspect of this
collection of information, including any
of the following subjects: (1) The
necessity and utility of the proposed
information collection for the proper
performance of the Agency’s function;
(2) the accuracy of the estimated
burden; (3) ways to enhance the quality,
utility, and clarity of the information to
be collected; and (4) the use of
automated collection techniques or
other forms of information technology to
minimize the information collection
burden.
1. Type of Information Collection
Request: Extension of a currently
approved collection; Title of
Information Collection: Collection
Requirements for Compendia for
Determination of Medically-accepted
Indications for Off-label Uses of Drugs
and Biologicals in an Anti-cancer
Chemotherapeutic Regimen Use:
Section 182(b) of the Medicare
Improvement of Patients and Providers
Act (MIPPA) amended section
1861(t)(2)(B) of the Social Security Act
(42 U.S.C. 1395x(t)(2)(B)) by adding at
the end the following new sentence: ‘On
and after January 1, 2010, no compendia
may be included on the list of
compendia under this subparagraph
unless the compendia has a publicly
transparent process for evaluating
therapies and for identifying potential
conflicts of interest.’ We believe that the
implementation of this statutory
provision that compendia have a
‘‘publicly transparent process for
evaluating therapies and for identifying
potential conflicts of interests’’ is best
accomplished by amending 42 CFR
414.930 to include the MIPPA
requirements and by defining the key
components of publicly transparent
AGENCY:
E:\FR\FM\31MYN1.SGM
31MYN1
tkelley on DSK3SPTVN1PROD with NOTICES
32658
Federal Register / Vol. 78, No. 105 / Friday, May 31, 2013 / Notices
processes for evaluating therapies and
for identifying potential conflicts of
interests.
All currently listed compendia will be
required to comply with these
provisions, as of January 1, 2010, to
remain on the list of recognized
compendia. In addition, any
compendium that is the subject of a
future request for inclusion on the list
of recognized compendia will be
required to comply with these
provisions. No compendium can be on
the list if it does not fully meet the
standard described in section
1861(t)(2)(B) of the Act, as revised by
section 182(b) of the MIPPA. Form
Number: CMS–10302 (OCN: 0938–
1078); Frequency: Annually; Affected
Public: Business and other for-profits
and Not-for-profit institutions; Number
of Respondents: 845; Total Annual
Responses: 900; Total Annual Hours:
5,135. (For policy questions regarding
this collection contact Brijet Coachman
at 410–786–7364. For all other issues
call 410–786–1326.)
2. Type of Information Collection
Request: Reinstatement of a currently
approved collection; Title: Medicare
Program: Procedures for Making
National Coverage Decisions; Use: We
revised our April 27, 1999 (64 FR
22619) notice and published a new
notice on September 26, 2003 (68 FR
55634) that described the process we
use to make Medicare coverage
decisions including decisions regarding
whether new technology and services
can be covered. We have made changes
to our internal procedures in response
to the comments we received following
publication of the 1999 notice and
experience under our new process. Over
the past several years, we received
numerous suggestions to further revise
our process to continue to make it more
open, responsive, and understandable to
the public. We share the goal of
increasing public participation in the
development of Medicare coverage
issues. This will assist us in obtaining
the information we require to make a
national coverage determination in a
timely manner and ensuring that the
Medicare program continues to meet the
needs of its beneficiaries. Form Number:
CMS–R–290 (OCN: 0938–0776);
Frequency: Annual; Affected Public:
Private sector: Business or other forprofits; Number of Respondents: 200;
Total Annual Responses: 200; Total
Annual Hours: 8,000. (For policy
questions regarding this collection
contact Katherine Tillman at 410–786–
9252. For all other issues call 410–786–
1326.)
1. Type of Information Collection
Request: New collection (Request for a
VerDate Mar<15>2010
17:40 May 30, 2013
Jkt 229001
new control number; Title of
Information Collection: Generic Social
Marketing & Consumer Testing
Research; Use: The purpose of this
submission is to request an Information
Collection Request (ICR) generic
clearance for a program of consumer
research aimed at a broad audience of
those affected by CMS programs
including Medicare, Medicaid,
Children’s Health Insurance Program
(CHIP), and health insurance exchanges.
This program extends strategic efforts to
reach and tailor communications to
beneficiaries, caregivers, providers,
stakeholders, and any other audiences
that would support the Agency in
improving the functioning of the health
care system, improve patient care and
outcomes, and reduce costs without
sacrificing quality of care. With the
clearance, we will create a streamlined
and proactive process for collection of
data and utilizing the feedback on
service delivery for continuous
improvement of communication
activities aimed at diverse CMS
audiences.
The generic clearance will allow rapid
response to inform CMS initiatives
using a mixture of qualitative and
quantitative consumer research
strategies (including formative research
studies and methodological tests) to
improve communication with key CMS
audiences. As new information
resources and persuasive technologies
are developed, they can be tested and
evaluated for beneficiary response to the
materials and delivery channels. Results
will inform communication
development and information
architecture as well as allow for
continuous quality improvement. The
overall goal is to maximize the extent to
which consumers have access to useful
sources of CMS program information in
a form that can help them make the
most of their benefits and options
The activities under this clearance
involve social marketing and consumer
research using samples of self-selected
customers, as well as convenience
samples, and quota samples, with
respondents selected either to cover a
broad range of customers or to include
specific characteristics related to certain
products or services. All collection of
information under this clearance will
utilize a subset of items drawn from a
core collection of customizable items
referred to as the Social Marketing and
Consumer Testing Item Bank. This item
bank is designed to establish a set of
pre-approved generic questions that can
be drawn upon to allow for the rapid
turn-around consumer testing required
for us to communicate more effectively
with our audiences. The questions in
PO 00000
Frm 00037
Fmt 4703
Sfmt 9990
the item bank are divided into two
major categories. One set focuses on
characteristics of individuals and is
intended primarily for participant
screening and for use in structured
quantitative on-line or telephone
surveys. The other set is less structured
and is designed for use in qualitative
one-on-one and small group discussions
or collecting information related to
subjective impressions of test materials.
A Study Initiation Request Form
detailing each specific study
(description, methodology, estimated
burden) conducted under this clearance
will be submitted before any testing is
initialed. Results will be compiled and
disseminated so that future
communication can be informed by the
testing results. We will use the findings
to create the greatest possible public
benefit. Form Number: CMS–10437
(OCN: 0938-New); Frequency: Yearly;
Affected Public: Individuals. Number of
Respondents: 41,592. Number of
Responses: 28,800. Total Annual Hours:
21,488. (For policy questions regarding
this collection contact Julie Franklin at
410–786–8126. For all other issues call
410–786–1326.)
To obtain copies of the supporting
statement and any related forms for the
proposed paperwork collections
referenced above, access CMS Web site
address at https://www.cms.hhs.gov/
PaperworkReductionActof1995, or
Email your request, including your
address, phone number, OMB number,
and CMS document identifier, to
Paperwork@cms.hhs.gov, or call the
Reports Clearance Office on (410) 786–
1326.
To be assured consideration,
comments and recommendations for the
proposed information collections must
be received by the OMB desk officer at
the address below, no later than 5 p.m.
on July 1, 2013.
OMB, Office of Information and
Regulatory Affairs, Attention: CMS Desk
Officer, Fax Number: (202) 395–6974,
Email: OIRA_submission@omb.eop.gov.
Dated: May 28, 2013.
Martique Jones,
Deputy Director, Regulations Development
Group, Office of Strategic Operations and
Regulatory Affairs.
[FR Doc. 2013–12934 Filed 5–30–13; 8:45 am]
BILLING CODE 4120–01–P
E:\FR\FM\31MYN1.SGM
31MYN1
Agencies
[Federal Register Volume 78, Number 105 (Friday, May 31, 2013)]
[Notices]
[Pages 32657-32658]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2013-12934]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Medicare & Medicaid Services
[Document Identifiers: CMS-10302, CMS-R-290 and CMS-10437]
Agency Information Collection Activities: Submission for OMB
Review; Comment Request
AGENCY: Centers for Medicare & Medicaid Services, HHS.
In compliance with the requirement of section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995, the Centers for Medicare & Medicaid
Services (CMS), Department of Health and Human Services, is publishing
the following summary of proposed collections for public comment.
Interested persons are invited to send comments regarding this burden
estimate or any other aspect of this collection of information,
including any of the following subjects: (1) The necessity and utility
of the proposed information collection for the proper performance of
the Agency's function; (2) the accuracy of the estimated burden; (3)
ways to enhance the quality, utility, and clarity of the information to
be collected; and (4) the use of automated collection techniques or
other forms of information technology to minimize the information
collection burden.
1. Type of Information Collection Request: Extension of a currently
approved collection; Title of Information Collection: Collection
Requirements for Compendia for Determination of Medically-accepted
Indications for Off-label Uses of Drugs and Biologicals in an Anti-
cancer Chemotherapeutic Regimen Use: Section 182(b) of the Medicare
Improvement of Patients and Providers Act (MIPPA) amended section
1861(t)(2)(B) of the Social Security Act (42 U.S.C. 1395x(t)(2)(B)) by
adding at the end the following new sentence: `On and after January 1,
2010, no compendia may be included on the list of compendia under this
subparagraph unless the compendia has a publicly transparent process
for evaluating therapies and for identifying potential conflicts of
interest.' We believe that the implementation of this statutory
provision that compendia have a ``publicly transparent process for
evaluating therapies and for identifying potential conflicts of
interests'' is best accomplished by amending 42 CFR 414.930 to include
the MIPPA requirements and by defining the key components of publicly
transparent
[[Page 32658]]
processes for evaluating therapies and for identifying potential
conflicts of interests.
All currently listed compendia will be required to comply with
these provisions, as of January 1, 2010, to remain on the list of
recognized compendia. In addition, any compendium that is the subject
of a future request for inclusion on the list of recognized compendia
will be required to comply with these provisions. No compendium can be
on the list if it does not fully meet the standard described in section
1861(t)(2)(B) of the Act, as revised by section 182(b) of the MIPPA.
Form Number: CMS-10302 (OCN: 0938-1078); Frequency: Annually; Affected
Public: Business and other for-profits and Not-for-profit institutions;
Number of Respondents: 845; Total Annual Responses: 900; Total Annual
Hours: 5,135. (For policy questions regarding this collection contact
Brijet Coachman at 410-786-7364. For all other issues call 410-786-
1326.)
2. Type of Information Collection Request: Reinstatement of a
currently approved collection; Title: Medicare Program: Procedures for
Making National Coverage Decisions; Use: We revised our April 27, 1999
(64 FR 22619) notice and published a new notice on September 26, 2003
(68 FR 55634) that described the process we use to make Medicare
coverage decisions including decisions regarding whether new technology
and services can be covered. We have made changes to our internal
procedures in response to the comments we received following
publication of the 1999 notice and experience under our new process.
Over the past several years, we received numerous suggestions to
further revise our process to continue to make it more open,
responsive, and understandable to the public. We share the goal of
increasing public participation in the development of Medicare coverage
issues. This will assist us in obtaining the information we require to
make a national coverage determination in a timely manner and ensuring
that the Medicare program continues to meet the needs of its
beneficiaries. Form Number: CMS-R-290 (OCN: 0938-0776); Frequency:
Annual; Affected Public: Private sector: Business or other for-profits;
Number of Respondents: 200; Total Annual Responses: 200; Total Annual
Hours: 8,000. (For policy questions regarding this collection contact
Katherine Tillman at 410-786-9252. For all other issues call 410-786-
1326.)
1. Type of Information Collection Request: New collection (Request
for a new control number; Title of Information Collection: Generic
Social Marketing & Consumer Testing Research; Use: The purpose of this
submission is to request an Information Collection Request (ICR)
generic clearance for a program of consumer research aimed at a broad
audience of those affected by CMS programs including Medicare,
Medicaid, Children's Health Insurance Program (CHIP), and health
insurance exchanges. This program extends strategic efforts to reach
and tailor communications to beneficiaries, caregivers, providers,
stakeholders, and any other audiences that would support the Agency in
improving the functioning of the health care system, improve patient
care and outcomes, and reduce costs without sacrificing quality of
care. With the clearance, we will create a streamlined and proactive
process for collection of data and utilizing the feedback on service
delivery for continuous improvement of communication activities aimed
at diverse CMS audiences.
The generic clearance will allow rapid response to inform CMS
initiatives using a mixture of qualitative and quantitative consumer
research strategies (including formative research studies and
methodological tests) to improve communication with key CMS audiences.
As new information resources and persuasive technologies are developed,
they can be tested and evaluated for beneficiary response to the
materials and delivery channels. Results will inform communication
development and information architecture as well as allow for
continuous quality improvement. The overall goal is to maximize the
extent to which consumers have access to useful sources of CMS program
information in a form that can help them make the most of their
benefits and options
The activities under this clearance involve social marketing and
consumer research using samples of self-selected customers, as well as
convenience samples, and quota samples, with respondents selected
either to cover a broad range of customers or to include specific
characteristics related to certain products or services. All collection
of information under this clearance will utilize a subset of items
drawn from a core collection of customizable items referred to as the
Social Marketing and Consumer Testing Item Bank. This item bank is
designed to establish a set of pre-approved generic questions that can
be drawn upon to allow for the rapid turn-around consumer testing
required for us to communicate more effectively with our audiences. The
questions in the item bank are divided into two major categories. One
set focuses on characteristics of individuals and is intended primarily
for participant screening and for use in structured quantitative on-
line or telephone surveys. The other set is less structured and is
designed for use in qualitative one-on-one and small group discussions
or collecting information related to subjective impressions of test
materials. A Study Initiation Request Form detailing each specific
study (description, methodology, estimated burden) conducted under this
clearance will be submitted before any testing is initialed. Results
will be compiled and disseminated so that future communication can be
informed by the testing results. We will use the findings to create the
greatest possible public benefit. Form Number: CMS-10437 (OCN: 0938-
New); Frequency: Yearly; Affected Public: Individuals. Number of
Respondents: 41,592. Number of Responses: 28,800. Total Annual Hours:
21,488. (For policy questions regarding this collection contact Julie
Franklin at 410-786-8126. For all other issues call 410-786-1326.)
To obtain copies of the supporting statement and any related forms
for the proposed paperwork collections referenced above, access CMS Web
site address at https://www.cms.hhs.gov/PaperworkReductionActof1995, or
Email your request, including your address, phone number, OMB number,
and CMS document identifier, to Paperwork@cms.hhs.gov, or call the
Reports Clearance Office on (410) 786-1326.
To be assured consideration, comments and recommendations for the
proposed information collections must be received by the OMB desk
officer at the address below, no later than 5 p.m. on July 1, 2013.
OMB, Office of Information and Regulatory Affairs, Attention: CMS
Desk Officer, Fax Number: (202) 395-6974, Email: OIRA_submission@omb.eop.gov.
Dated: May 28, 2013.
Martique Jones,
Deputy Director, Regulations Development Group, Office of Strategic
Operations and Regulatory Affairs.
[FR Doc. 2013-12934 Filed 5-30-13; 8:45 am]
BILLING CODE 4120-01-P